Skip to main content
. 2018 Jul 25;7:e36340. doi: 10.7554/eLife.36340

Table 2. In vitro inhibition of HIV-1 reverse transcriptase by 25a and RPV.

RT variants 25a RPV
IC50 (nM) Fold R* Curve slope IC50 (nM) Fold R Curve slope
WT 4.3 ± 0.080 3.8 ± 0.70 3.5 ± 0.052 3.1 ± 0.17
K103N/Y181C 31 ± 0.83 7.2 1.9 ± 0.092 51 ± 1.5 15 1.4 ± 0.047
Y188L 3.0 ± 0.15 0.70 1.9 ± 0.16 7.6 ± 0.22 2.2 1.7 ± 0.069
V106A/F227L 7.3 ± 0.23 1.7 3.1 ± 0.17 14 ± 0.27 4.0 2.1 ± 0.083
K101P 5.4 ± 0.16 1.3 2.9 ± 0.21 71 ± 3.0 20 1.2 ± 0.056
Y181I 38 ± 1.1 8.8 2.3 ± 0.16 315 ± 15 90 1.4 ± 0.081
K103N/Y181I 412 ± 13 96 1.8 ± 0.094 6317 ± 339 1805 1.4 ± 0.10
P225H 2.5 ± 0.059 0.58 3.5 ± 0.15 3.7 ± 0.070 1.1 3.4 ± 0.34
P236L 2.6 ± 0.13 0.60 4.3 ± 0.43 3.7 ± 0.085 1.1 3.6 ± 0.47

* Mean fold change in the IC50 values of mutant RT versus WT RT.

† Data reported as mean ±standard error.